Azithromycin NDC 85766-077

NDC codes

FDA NDC Directory

Product NDC (as listed)85766-077Labeler and product segments. Claims need a package NDC.

Product NDC at billing width85766-0077Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package
85766-077-03	85766007703	1 BLISTER PACK in 1 CARTON (85766-077-03) / 3 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Oct 10, 2025
85766-077-09	85766007709	3 CARTON in 1 PACKAGE (85766-077-09) / 1 BLISTER PACK in 1 CARTON / 3 TABLET, FILM COATED in 1 BLISTER PACKMarketed from Oct 10, 2025
85766-077-30	85766007730	30 TABLET, FILM COATED in 1 BOTTLE (85766-077-30)Marketed from Oct 10, 2025

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Azithromycin
Generic name (nonproprietary): azithromycin
Active ingredients: Azithromycin monohydrate — 500 mg/1
Dosage form: Tablet, Film coated
Route: Oral
Labeler: Sportpharm LLC
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 065223
Marketing start: Jan 6, 2006
Listing expires: Dec 31, 2027
Other FDA classes: Macrolides (Chemical structure)
Identifiers: Product ID 85766-077_50318293-408d-c148-e063-6394a90a7168SPL ID 50318293-408d-c148-e063-6394a90a7168SPL set ID 397471e5-76e2-462c-af30-bcc54fe00266RxCUI 248656UNII JTE4MNN1MD
Pharmacologic class: Macrolide Antimicrobial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N485766007703 followed by a unit qualifier and the quantity

Package 85766-0077-03. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Apr 24, 2026.

Indications (excerpt from the label)

Azithromycin tablets are a macrolide antibacterial drug indicated for the treatment of patients with mild to moderate infections caused by susceptible strains of the designated microorganisms in the specific conditions listed below. Recommended dosages and durations of therapy in adult and pediatric patient populations vary in these indications [see Dosage and Administration ( 2 )]. Azithromycin tablets are a macrolide antibacterial drug indicated for mild to moderate infections caused by designated, susceptible bacteria: Acute bacterial exacerbations of chronic bronchitis in adults ( 1.1 ) Acute bacterial sinusitis in adults ( 1.1 ) Uncomplicated skin and skin structure infections in adults…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 065223

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 065223
Product	Strength	Form · route	Labeler	Product NDC
Azithromycin	Azithromycin monohydrate 500 mg/1	Tablet, Film coatedOral	REMEDYREPACK INC.	70518-0599
Azithromycin	Azithromycin monohydrate 500 mg/1	Tablet, Film coatedOral	Teva Pharmaceuticals USA, Inc.	50111-788
Azithromycin	Azithromycin monohydrate 500 mg/1	Tablet, Film coatedOral	Proficient Rx LP	63187-189
Azithromycin	Azithromycin monohydrate 500 mg/1	Tablet, Film coatedOral	Asclemed USA, Inc.	76420-589